Statement Of Comprehensive Income [Abstract]

Embla Medical hf - Filing #5889952

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Statement of comprehensive income [abstract]
Profit (loss)	682,000 USD	—	68,960,000 USD	—	—	68,278,000 USD	68,278,000 USD	—	58,801,000 USD	412,000 USD	58,389,000 USD	—	58,389,000 USD	—
Other comprehensive income [abstract]
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	—	12,860,000 USD	—	12,860,000 USD	—	12,860,000 USD	—	5,866,000 USD	—	—	—	5,866,000 USD	5,866,000 USD
Cash flow hedges [abstract]
Reclassification adjustments on cash flow hedges, net of tax	—	—	66,000 USD	—	66,000 USD	—	66,000 USD	—	70,000 USD	—	—	—	70,000 USD	70,000 USD
Other comprehensive income, net of tax, cash flow hedges	—	—	1,466,000 USD	—	1,466,000 USD	—	1,466,000 USD	—	770,000 USD	—	—	—	770,000 USD	770,000 USD
Other comprehensive income	—	—	11,328,000 USD	—	—	—	—	—	6,706,000 USD	—	—	—	—	—
Comprehensive income	682,000 USD	0 USD	57,632,000 USD	0 USD	11,328,000 USD	68,278,000 USD	56,950,000 USD	0 USD	65,507,000 USD	412,000 USD	58,389,000 USD	0 USD	65,095,000 USD	6,706,000 USD
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	—	56,950,000 USD	—	—	—	—	—	65,095,000 USD	—	—	—	—	—
Comprehensive income, attributable to non-controlling interests	—	—	682,000 USD	—	—	—	—	—	412,000 USD	—	—	—	—	—